JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2010, Vol. 48 ›› Issue (11): 29-32.

• Articles • Previous Articles     Next Articles

Construction of the recombinant plasmid pEGFP-N1-ZIP10 and its effect  on expressions of other zinc transporters in breast cancer cells

GUO Lu1, HU Xiao-yan1, JIANG Ya-li1, XU Tong-fu1, WANG Pin2, LI Ming2, ZHANG Lian-ying1   

  1. Shandong University School of Medicine 1. Department of Biochemistry and Molecular Biology, Jinan 250012, China;
    2. Clinical Seven-year students,  School of Medicine, Jinan 250012, China
  • Received:2010-06-28 Online:2010-11-16 Published:2010-11-16

Abstract:

Objective    To construct the pEGFP-N1-ZIP10 expression vector and observe its expression in human breast cancer MCF-7 and MDA-MB-231 cell lines, and also to detect expressions of other zinc transporters when ZIP10 is over-expressed. Methods    The target sequence of ZIP10 was obtained and amplified from human blood by RT-PCR. Then, the cDNA segment was cloned into eukaryote plasmid pEGFP-N1. The pEGFP-N1-ZIP10 was identified by restriction enzyme digestion and checked by DNA sequence analysis. MCF-7 and MDA-MB-231 cells were transiently transfected, and expressions of ZIP10 and other zinc transporters were detected by RT-PCR. Results    Identification of pEGFP-N1-ZIP10 by enzyme digestion and PCR showed that the length, location of insertion and direction of the target gene inserted into the recombinant were correct. After the transfection, over-expression of ZIP10 was found in human breast cancer MCF-7 and MDA-MB-231 cells, while expression of ZIP1 was significantly reduced in the transfected cells. Conclusion     The eukaryotic expression plasmid pEGFP-N1-ZIP10 has been successfully constructed and it can be expressed transiently in MCF-7 and  MDA-MB-231 cells.  The decreased expression of ZIP1 in the transfected cells may indicate the role of ZIP10 in breast carcinogenesis and development.

Key words: Breast cancer cells; ZIP10; ZIP1; Expression vector

CLC Number: 

  • R737.9
[1] MA Zhen-shen1, WANG Da-wei2, SUN Xiu-bin3, SHI Hao1, PANG Tao1, DONG Gui-qing1, ZHANG Cheng-qi1. Quantitative analysis of 3.0T MR in differential diagnosis of breast lesions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(9): 79-83.
[2] CHI Wei-wei1, GAO Hai-yan2, GAO Hai-dong3. The molecular mechanism of transforming growth factor-β1-induced transmembrane protein participating in the development of breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(4): 26-29.
[3] LI Shan-shan, SUN Ying, DING Huan, LI Li. β-catenin expressions in different subtypes of breast cancer and its clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 107-110.
[4] CEN Dong-zhi. Overexpression of NRIP3  gene inhibited metastasis in lymph node
negative breast cancer
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 83-.
[5] WANG Jing-nan1, ZHENG Yan2, XIAO Dong-jie2, LI Jin-xing1, DING Bu-tong2, LIU Xiang-dong3, WANG Yun-shan2,4. Correlation between  SATB1 and HER2 expressions and
 the tumor grade in breast cancer
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 91-.
[6] ZHANG Jia-xin, MA Zhong-bing, YU Li-xiang, LIU Li-yuan, WANG Fei, GUO Ming-ming, WANG Feng, YU Zhi-gang. Associations between breast cancer and serum
levels of adiponectin and leptin
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(6): 110-.
[7] WAN Yue, CHEN Shou-hua, GU He, ZHANG Li-li. Effects of bortezomib in combination with epirubicin on the
proliferation and apoptosis of breast cancer cells
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 43-46.
[8] DU Jin-ling1, LIU De-xiang1, CHEN Wen-qiang2, JIANG Hong1, ZHANG Qian1, Pan Fang1. Stress responses and related factors of patients with coronary
heart disease after coronary intervention
[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 131-.
[9] WANG Xin-gang1,2, WANG Xiao-feng3, LI Fu-nian2, HOU Lin4, YANG Qi-feng1. Effects of epigenetic drugs on BRCA1 and CHD5 expressions in breast cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(7): 29-34.
[10] GUO Ming-ming, YU Zhi-gang, MA Zhong-bing, GAO De-zong, LI Liang, LI Yu-yang, ZHANG Qiang, WANG Feng, WANG Fei, FU Qin-ye. Microarray-based gene expression profiles related to breast cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(7): 94-99.
[11] WANG Ze-jun1, XU Cheng-wei1, MA Xiao-li2, ZHENG Yan2, JIA Yan-fei2, XIAO Dong-jie2, WANG Yun-shan2 . Effect of CPB2 gene silencing on TAFI expression and   metastasis in breast cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 57-.
[12] YANG Hua-wei, LIU Jian-lun, JIANG Yi,TANG Wei,WEI Wei ,HUANG Zhen. Expression of lysyl oxidase in breast cancer and its clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 136-140.
[13] WANG Xing-miao1, LI Meng-quan1, WANG Li-juan2, SU Jing1, HU Di1. Expressions of Caspase-3, OPN and Ezrin in invasive ductal  carcinoma of breasts and their clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 141-145.
[14] XU Yue-juan, QIU Shao-min. Expressions of estrogen receptor, progesterone receptor and c-erbB-2and their relationship with prognosis in breast carcinoma tissues [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(9): 100-103.
[15] LIU Yun-cong1, RAN Li2, XIE Fei3, TAN Shi-sheng1, LI Hang1. Expression of BclXl and its relationship with clinical pathology in breast cancer tissues [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(9): 104-106.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!